Last reviewed · How we verify
NCT05308238
Pre-Active PD: Looking At Physical Activity Behavior Change in Parkinson's Disease
NA trial testing Occupational therapy intervention group in Parkinson Disease in 50 participants. Completed in 13 March 2024.
13 March 2024
Quick facts
| Lead sponsor | San Jose State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 18 April 2022 |
| Primary completion | 13 March 2024 |
| Estimated completion | 13 March 2024 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Occupational therapy intervention group
- Disease management education group
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
Sponsor
San Jose State University
Who can join
Adults 18 to 85, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pre-Active PD is a randomized controlled feasibility study to evaluate the implementation of a telehealth-delivered physical activity behavior change intervention for people with early-mid stage Parkinson's disease. The program utilizes occupational therapists to provide one-to-one individualized support to facilitate and optimize exercise uptake as part of their disease self-management. The structure of the intervention is based on previous research in neurodegenerative disease including Parkinson's disease and Huntington's disease.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Clinical Trial Highlights - Interventions Promoting Physical Activity in Parkinson's Disease.
Oosterhof TH, Schootemeijer S, de Vries NM. · · 2023 · cited 4× · PMID 37125564 · DOI 10.3233/jpd-239001
Verify or expand the search:
- PubMed search for NCT05308238
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other San Jose State University trials
Trials by the same sponsor.
- NCT05913869 — Online Mindfulness-based Program for Parents of Children With Autism · NA · active not recruiting
- NCT05126485 — Biofeedback Retention in Individuals With AKA · EARLY_PHASE1 · unknown
- NCT05070117 — The Effect of Exercise Training on Musculoskeletal Health in Individuals With Cerebral Palsy · NA · completed
- NCT04007913 — Incorporating teleCBIT Into a Hospital-Based Tic Program · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05308238 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by San Jose State University
- Last refreshed: 19 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05308238.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing